Xeris Biopharma Holdings Inc (XERS)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current XERS market cap is 312.82M. The company's latest EPS is USD -0.4199 and P/E is -5.00.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |||
| Total Revenue | 33.2M | 38.01M | 48.32M | 44.39M | 40.64M |
| Operating Income | -13.28M | -15.98M | -4.91M | -9.84M | -14.25M |
| Net Income | -16.83M | -19.84M | -12.19M | -13.39M | -18.98M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 49.59M | 110.25M | 163.91M |
| Operating Income | -115.16M | -81.94M | -44.01M |
| Net Income | -122.73M | -94.66M | -62.26M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |||
| Total Assets | 321.36M | 328.78M | 327.78M | 322.6M | 336.62M |
| Total Liabilities | 291.31M | 315.14M | 323.92M | 329.38M | 345.79M |
| Total Equity | 30.05M | 13.64M | 3.87M | -6.78M | -9.18M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Assets | 304.36M | 344.52M | 322.6M |
| Total Liabilities | 209.13M | 299.34M | 329.38M |
| Total Equity | 95.23M | 45.19M | -6.78M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |||
| Operating | -26.14M | -39.88M | -54.49M | -47.02M | -20.3M |
| Investing | -43.98M | -35.53M | -20.87M | -6M | -19.65M |
| Financing | -863k | -307k | -379k | -1.61M | 35.19M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Operating | -95.54M | -102.89M | -47.02M |
| Investing | 97.96M | 34.46M | -6M |
| Financing | 27.25M | 127.47M | -1.61M |
| Market Cap | 312.82M |
| Price to Earnings Ratio | -5.00 |
| Price to Sales Ratio | 1.9 |
| Price to Cash Ratio | 4.62 |
| Price to Book Ratio | -45.91 |
| Dividend Yield | - |
| Shares Outstanding | 148.26M |
| Average Volume (1 week) | 943.72k |
| Average Volume (1 Month) | 1.07M |
| 52 Week Change | -16.60% |
| 52 Week High | 3.26 |
| 52 Week Low | 1.46 |
| Spread (Intraday) | 0.14 (6.36%) |
| Company Name | Xeris Biopharma Holdings Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.xerispharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
